The FDA's fast track designation aims to expedite ITM-94's development for diagnosing clear cell renal cell carcinoma. The ...

Cell C has cut the offer price for its imminent JSE debut, trimming as much as R3.50/share off the bottom of the original ...

A newly recognized set of T helper cells seems to guard against aging by eliminating harmful senescent cells. Their presence ...

ITM-94 forms a theranostic pair with therapeutic candidate ITM-91, targeting carbonic anhydrase IX (CAIX) in clear cell renal ...

Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the ...

Scientists have discovered that the brain may have a built-in way to fight Alzheimer’s.

DPI-4452 targets CAIX in tumors, offering noninvasive diagnostic potential for ccRCC with favorable tolerability. The agent is part of a theranostic pair wi ...

In stunning new time-lapse videos, biological nanoparticles scoot and flit across a starry field of glowing dots. Guided by ...

Current risk stratification models perform well in assessing recurrence risk in patients with non-clear cell renal cell carcinoma, researchers report.

Once thought to be a flaw in the system, new research suggests that CD4 T cells may actually hold the key to maintaining a ...

An AI-based model for analyzing images appeared better able to predict ccRCC from CT-based images than a tumor size-based model was.

When autophagy faltered in these pre cancer cells, unwanted protein molecules began to build up and stick together. The ...